Bioanalytical Systems Reschedules Fourth Quarter & Fiscal 2013 Earnings
Release to Tuesday, December 24, 2013; Conference Call & Webcast Set For
11:00 a.m. EST
WEST LAFAYETTE, Ind. -- December 19, 2013
Bioanalytical Systems, Inc. (NASDAQ:BASI) has rescheduled the release of
financial results for the fourth quarter and fiscal 2013 ended September 30,
2013 to Tuesday, December 24, 2013. BASi has scheduled a conference call at
11:00 a.m. EST that morning to discuss its results for the quarter. To
participate in the call, dial 866.825.1709, passcode #95235310.
A simultaneous webcast of the conference call may be accessed online from the
Investors tab at www.BASinc.com. The webcast will be available for replay
after 2:00 p.m. EST at this same Internet address. For a telephone replay,
dial 888.286.8010, passcode #65530693 after 2:00 p.m. EST.
About Bioanalytical Systems, Inc.
BASi is a pharmaceutical development company providing contract research
services and monitoring instruments to the world's leading drug development
companies and medical research organizations. The company focuses on
developing innovative services and products that increase efficiency and
reduce the cost of taking a new drug to market. Visit www.BASinc.com for more
This release may contain forward-looking statements that are subject to risks
and uncertainties including, but not limited to, risks and uncertainties
related to changes in the market and demand for our products and services, the
development, marketing and sales of products and services, changes in
technology, industry standards and regulatory standards, and various market
and operating risks detailed in the company's filings with the Securities and
Bioanalytical Systems, Inc.
President, CEO and CFO
Press spacebar to pause and continue. Press esc to stop.